P49 | From guidelines to a care pathway: "Diabetes is close to our hearts at the hospital"
M. Conti1, G. Vella2, M. Renda1, D. Armata3, S. Lo Iacono3, A. Caronia3, T. Cipolla4, F. Rubino5 | 1Medicina Interna, Fondazione G. Giglio, Cefalù (PA), 2Università degli Studi di Palermo, 3Cardiologia, Fondazione G. Giglio, Cefalù (PA), 4Cardiologia, Fondazione G. Giglio, Cefalù (PA), 5Riabilitazione, Fondazione G. Giglio, Cefalù (PA), Italy
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Premises: The 2023 intersociety guidelines on the management of diabetic or hyperglycemic patients admitted to a non-critical setting reiterated that it is desirable to adopt an organizational model that includes the intervention of personnel with diabetological expertise where available, and that a structured discharge plan is more cost-effective than a discharge method that does not include one. In 2023, the Internal Medicine department at Giglio Hospital in Cefalù created an outpatient service for the care and follow-up of diabetic patients after hospitalization, with direct access and appointments within a month of discharge.
Materials and Methods: Between February 2023 and January 2024, 120 subjects were admitted (58% discharged from medicine, 39% from cardiology-rehabilitation, 3% from other departments), and the changes in HbA1c, the use of insulin, GLP1RA, or SGLT2i during hospitalization and follow-up (1/3/6 months) were retrospectively evaluated in 100 of them.
Results: Compared to background antidiabetic therapy, the use of innovative molecules (GLP1RAs or SGLT2is) increased statistically significantly during hospitalization, remained constant in subsequent check-ups, and contributed to a statistically significant reduction in mean HbA1c and insulin requirements. The readmission rate was <2%.
Conclusions: The PDTA for people with diabetes admitted to Cefalù Hospital represents an effective tool for improving diabetes outcomes and promoting adherence to a chronic care plan that is more in line with current Italian guidelines.
Altmetrics
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.